ACCESS Newswire
ACCESS Newswire
More ACCESS Newswire
View Older Stories View Newer Stories-
Rockhaven Announces Improved Metallurgical Test Work Results on its Klaza Project, Yukon
-
1847 Re-Engages ShareIntel to Investigate Potentially Improper and Illegal Trading Activity in the Company’s Common Stock
-
GOAI and Smart Money Capital Forge Partnership to Optimize Lead Generation
-
Inspire Veterinary Partners Announces 1-for-100 Reverse Stock Split
-
Atlantic Power & Infrastructure’s latest installation marks more than 15 years of installing Flexi(R)-Pave in Key West, Florida
-
Loar Holdings Inc. Announces Addition of Paul Dolan as Executive Vice President
-
ARIA Cybersecurity Wins Global Infosec Cybersecurity Product Award for AZT PROTECT
-
Southern California Wine Visionaries Phil and Carol Baily of Baily Winery Inducted Into the Temecula Valley Wine Country Hall of Fame
-
Quartz To Raise $3.26 Million Including New Key Investor
-
Phoenix Motor to Unveil New Branding at ACT Expo 2024
-
Pampa Metals Intersects 448 m @ 0.42% Cu, 0.46 g/t Au including 126m @ 0.66% Cu, 0.74 g/t Au in Second Drillhole at Piuquenes, Argentina
-
Canada Jetlines to Announce Q1 2024 Earnings Results
-
Gryphon Digital Mining Announces April Operational Update
-
Aclara Awards the Carina Module Pre-Feasibility Study Contract To Hatch
-
Grid Metals Announces Indicated Open-Pit Mineral Resource of 46.2 Million Tonnes at MM Copper/Nickel Project in Southeastern Manitoba
-
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
-
Electrovaya Presenting at the Upcoming EXIM Bank Annual Conference
-
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
-
TDG Gold Corp. Announces Extension of Non-Brokered Private Placement
-
Eagle Plains Completes Initial Compilation on Theory Copper-Gold Project in the Toodoggone District
-
Lahontan Engages Kappes, Cassiday And Associates For Santa Fe Preliminary Economic Assesment
-
Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
-
Optex Systems Announces $3.8 Million Order for Laser Protected Periscopes
-
Silver Wolf Engages Strategic Financial Advisory Firm Salman Partners
-
Ondas Secures Initial Purchase Order from a Major Defense Company for its Autonomous Counter-Drone System the Iron-Drone Raider
-
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
-
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
-
Idaho Strategic Reports First Quarter 2024 Operating and Financial Performance
-
BIOLASE to Report First Quarter 2024 Results on May 13, 2024
-
Cerrado Gold Announces Receipt of Second Advance Under Secured Loan From Subsidiary of Hochschild Mining PLC
-
ZeroBounce Launches Verify+ to Help Reduce Email Bounces From Disabled Yahoo-Related Email Addresses
-
Notice To Annual General Meeting of Spago Nanomedical AB (Publ)
-
GoldTrust Announces 3 Leading Gold IRA Companies in the USA [2024]
-
Team Cymru Launches Pure Signal(TM) Scout Insight for Enhanced Proactive Security With Advanced External Threat Intelligence
-
Phoenix Motor to Unveil New Branding at ACT Expo 2024
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB: Invitation to the Interim Report for Q1 2024 Presentation and Webcast
-
Pursuit Church Announces Interfaith March for Israel at University of Southern California
-
BlackTieCBD.Net Announces Expanded Selection of THC-A Flower, Including Award-Winning Strains
-
Wine Country Inn Offers High End Charging Stations
-
Iris Indie International Announces New Distribution Division and Appointment of Milena Rimassa as Its President
